Maintenance Therapies for Hodgkin and Non-HodgEn Lymphomas After Autologous Transplantation A Consensus Project of ASBMT, CIBMTR, and the Lymphima Working Party of EBMT

Kanate, AS; Kumar, A; Dreger, P; Dreyling, M; Le Gouill, S; Corradini, P; Bredeson, C; Fenske, TS; Smith, SM; Sureda, A; Moskowitz, A; Friedberg, JW; Inwards, DJ; Herrera, AF; Kharfan-Dabaja, MA; Reddy, N; Montoto, S; Robinson, SP; Abutalib, SA; Giss

Hamadani, M (reprint author), CIBMTR, BMT & Cellular Therapy Program, 9200 W Wisconsin Ave,Ste C5500, Milwaukee, WI 53226 USA.; Hamadani, M (reprint author), Med Coll Wisconsin, 9200 W Wisconsin Ave,Ste C5500, Milwaukee, WI 53226 USA.

JAMA ONCOLOGY, 2019; 5 (5): 715

Abstract

IMPORTANCE Maintenance therapies are often considered as a therapeutic strategy in patients with lymphoma following autologous hematopoietic cell tran......

Full Text Link